“novartis” Archives

in
Entry Author Date Location
After $1M NEI Grant, ONL Therapeutics Closer to Clinical Trials 03/27/17 Detroit Ann Arbor
Ionis Pharma Spins Out Lipid Disorder Unit Akcea with Plans for IPO 03/27/17 Boston
Bio Roundup: Trumpcare Wavers, Amgen Courts Payers, Critics Circle PTC 03/24/17 National
First Trial in Sight, Editas Cuts $90M Eye Drug Deal With Allergan 03/14/17 Boston
Possible Cures. Mystery Deaths. Daunting Costs. Can CAR-T Be Tamed? 03/13/17 National
Biotech Vet Dunsire’s New Challenge: Grow Tiny Startup, XTuit 03/08/17 Boston
After Trial Deaths, Juno Pivots and Scraps Lead CAR-T Therapy 03/01/17 Seattle
Seventh Sense Gets Initial FDA Clearance for Simple Blood-Draw Device 02/23/17 Boston
NeuroPointDX, JCI, Resnick, & More: This Week’s Wisconsin Watchlist 02/13/17 Wisconsin
Propeller Health, Novartis to Develop Add-On Sensor for Breezhaler 02/08/17 Wisconsin
Bio Roundup: Trump News, Anthem’s Stand, Diversity by 2056 & More 01/27/17 National
Bio Roundup: Crazy ’16, Trials of ’17, Senate on Drugs & More 12/23/16 National
14 for ’17: Key Clinical Data To Watch For Next Year (Part 2) 12/22/16 National
Proteon’s Blood Vessel Drug Flunks Main Phase 3 Test, Shares Plummet 12/13/16 Boston
Ophthotech Eye Drug Fails Badly in Pivotal Test, Shares Crumble 12/12/16 New York
Bio Roundup: Fast “Cures,” Trump In Time, CRISPR In Court & More 12/09/16 National
At Late-Night ASH Talk, Juno Execs Look Beyond Stalled “Rocket” Trial 12/06/16 Seattle
ASH Roundup: CAR-T Shuffle, Hemophilia Updates, Checkpoint Progress & More 12/06/16 National
The Xconomy Immuno-Oncology Resource: A Mid-ASH T Cell Update 12/05/16 National
Seventh Sense Biosystems Sucks In $10M for Simple Blood-Draw Device 11/18/16 Boston
On Front Lines Of Price Dispute, Eye Doctors Wary of New Drug Data 11/01/16 National
Safety Issue Triggers Partial FDA Hold for Aduro Bio 10/24/16 San Francisco
All In One Place: A New Immuno-Oncology Trial Resource 10/19/16 National
Ocular Therapeutix Inks Licensing Deal With Regeneron For Wet AMD 10/13/16 Boston
Checkpoints In Lung Cancer, and Other Oncology News From Europe 10/11/16 National
Elanco Reaches $885M Deal for Boehringer’s Pet Vaccines Portfolio 10/05/16 Indiana
Taking Aim at Alexion, Ra Pharma Heads to IPO Queue 10/03/16 Boston
Aligned With Roche, SQZ Bio Gets $16M to Push Cell Therapies to Clinic 09/30/16 Boston
Caribou CEO Touts Incubator’s Role Translating Science into Startup 09/29/16 Texas
Will Programmable Immune “Cellbots” Be the Next Weapon Against Cancer? 09/29/16 San Francisco
Page 1 of 18 next page »